Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Accounts Payables (2023 - 2025)

Historic Accounts Payables for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $1.2 million.

  • Metagenomi's Accounts Payables fell 6084.43% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 6084.43%. This contributed to the annual value of $533000.0 for FY2024, which is 7024.01% down from last year.
  • According to the latest figures from Q3 2025, Metagenomi's Accounts Payables is $1.2 million, which was down 6084.43% from $2.9 million recorded in Q2 2025.
  • In the past 5 years, Metagenomi's Accounts Payables registered a high of $6.8 million during Q1 2024, and its lowest value of $533000.0 during Q4 2024.
  • Its 3-year average for Accounts Payables is $2.8 million, with a median of $2.8 million in 2025.
  • Its Accounts Payables has fluctuated over the past 5 years, first crashed by 7024.01% in 2024, then plummeted by 1627.57% in 2025.
  • Metagenomi's Accounts Payables (Quarter) stood at $1.8 million in 2023, then tumbled by 70.24% to $533000.0 in 2024, then skyrocketed by 127.95% to $1.2 million in 2025.
  • Its Accounts Payables stands at $1.2 million for Q3 2025, versus $2.9 million for Q2 2025 and $2.7 million for Q1 2025.